https://ncx-receptor.com/index.....php/characteristics
To find specific serum metabolites as potential biomarkers to differentiate pancreatic carcinoma from harmless disease (BD) is on urgent demand. METHOD To comprehensively evaluate serum metabolites obtained from 14 patients with PC, 10 clients with BD and 10 healthy individuals (normal control, NC), we separated the metabolites using both reversed-phase liquid chromatography (RPLC) and hydrophilic discussion fluid chromatography (HILIC). The information
Like
Comment
Share
